Neurosurgery
Division of Spine and Peripheral Nerve Surgery at Stanford

Spine and Peripheral Nerve Surgery Clinical Trials

North American Clinical Trials Network (NACTN)

The Department of Neurosurgery is a member of the North American Clinical Trials Network (NACTN) for Treatment of Spinal Cord Injury, whose mission is to bring promising therapies out of the laboratory and into clinical trials.  A recent Phase I trial showed that the oral medication Riluzole may have some efficacy in reducing impairment if given during the first two weeks after spinal cord injury. A Phase II trial is now being planned to examine the safety and efficacy of Riluzole in more detail.
PI: Graham Creasey

The Canadian Multicentre CSF Monitoring and Biomarker Study (CAMPER)

The Department of Neurosurgery will this year become the first US site in this multi-center study supported by the Rick Hansen Institute of Canada to monitor pressure around the spinal cord during the first week after spinal cord injury and to sample cerebrospinal fluid for biomarkers of injury.
PI: Graham Creasey

Evaluation of Pudendal Nerve Block and Stimulation for Voiding and Continence

This Phase I four-year clinical trial supported by the Department of Defense will evaluate a second generation neural prosthesis for restoring bladder emptying and continence using electrical stimulation without posterior rhizotomy.
PI: Graham Creasey

Contact for clinical trials:

Maria Coburn
mcoburn@stanford.edu


Stanford Medicine Resources:

Footer Links: